767 results on '"Lengerke, Claudia"'
Search Results
2. Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemia
3. Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review
4. The Future of CAR T Therapeutics to Treat Autoimmune Disorders
5. Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome
6. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
7. The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia
8. Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate
9. CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia
10. Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT
11. Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series
12. BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis
13. Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
14. Bedeutung der klonalen Hämatopoese für hämatologische Neoplasien
15. 47/w mit Trizytopenie nach Chemotherapie bei Mammakarzinom: Vorbereitung auf die Facharztprüfung: Fall 21
16. Culturing patient-derived malignant hematopoietic stem cells in engineered and fully humanized 3D niches
17. Adenovirus‐ and cytomegalovirus‐specific adoptive T‐cell therapy in the context of hematologic cell transplan or HIV infection – A single‐center experience
18. GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany
19. Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
20. GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
21. Asymmetric organelle inheritance predicts human blood stem cell fate
22. Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre‐B acute lymphoblastic leukemia
23. Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports
24. Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype
25. CRISPR/Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia
26. 47/w mit Trizytopenie nach Chemotherapie bei Mammakarzinom: Vorbereitung auf die Facharztprüfung: Fall 21
27. Intra-Tumor Cell Heterogeneity: Different Immune Responses for Different Cells
28. SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicing
29. Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT
30. Klonale Hämatopoese – Alterungsmerkmal oder Vorbote einer Erkrankung?
31. Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).
32. Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia.
33. PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity
34. Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model
35. Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host disease in gastrointestinal biopsies
36. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond
37. VCAM1 as a don’t-eat-me molecule
38. The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia
39. Rational Combinatorial Targeting by Adapter CAR T Cells (AdCAR-T) Prevents Antigen Escape in Acute Myeloid Leukemia (AML)
40. Krebs in der Schwangerschaft: Diagnose, Behandlungsoptionen und Outcome
41. Tuning of granulopoietic signaling byde novodesigned agonists
42. Chemotherapie maligner Tumore
43. Supplementary Figures S1-S13 from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
44. Data from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
45. 836 A novel PD-L1 antibody-IL10 fusion protein, PTL011, exhibits synergized therapeutic effect in hepatocellular carcinoma mouse model
46. Supplementary Tables S1 to S15 from Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
47. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
48. Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia
49. In vitro biomimetic engineering of a human hematopoietic niche with functional properties
50. Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.